| |
CHF patients n=389 |
CAD patients=319 |
P |
| Age, year |
57 ± 10 |
64 ± 10 |
<0.01 |
| Male, n% |
326 (84%) |
249 (78%) |
<0.01 |
| BMI, kg/m2 |
24 ± 3 |
25 ± 3 |
Ns |
| Hypertension, n% |
175 (45%) |
185 (58%) |
<0.05 |
| Smoking, n% |
245 (63%) |
217 (68%) |
<0.05 |
| Dyslipidemia, n% |
226 (58%) |
265 (83%) |
<0.01 |
| Diabetes mellitus, n% |
90 (23%) |
102 (32%) |
<0.01 |
| Medical treatment |
|
|
|
| Beta-blocker, n% |
342 (87%) |
239 (75%) |
<0.01 |
| ACE-inhibitor, n% |
323 (83%) |
169 (53%) |
<0.01 |
| Nitrates, n% |
171 (43%) |
182 (57%) |
<0.01 |
| Ca-antagonist, n% |
74 (19%) |
86 (27%) |
<0.05 |
| Diuretic, n% |
319 (82%) |
128 (40%) |
<0.01 |
| Statin, n% |
198 (51%) |
255 (80%) |
<0.01 |
| LVEF, % |
35 ± 7 |
58 ± 5 |
<0.01 |
| LVV, ml |
198 ± 83 |
94 ± 58 |
<0.01 |
| Total cholesterol, mg/dl |
192 ± 43 |
189 ± 40 |
<0.05 |
| HDL cholesterol, mg/dl |
45 ± 13 |
48 ± 22 |
Ns |
| Triglycerides, mg/dl |
149 ± 60 |
152 ± 54 |
Ns |
| Creatinin, mg/dl |
1.6 ± 0.4 |
1.1 ± 0.5 |
<0.05 |
| WBC, n/ul |
8650 ± 1264 |
7468 ± 1456 |
Ns |
| Hemoglobin, g/l |
11.2 ± 2.2 |
12.3 ± 2.5 |
Ns |
| sRAGE, ng/ml |
659 (470-920) |
950 (730-1200) |
<0.05 |
CHF=Chronic Heart Failure; CAD=Coronary Artery Disease; LVEF=Left Ventricular
Ejection Fraction; LVV=Left Ventricle Volume; WBC=White Blood Cells |
